Animal Health

Ceva Animal Health appoints former Virbac CEO Sébastien Huron as Deputy CEO, creating a dual leadership aimed at accelerating growth and operational might.

A new connected vaccine tag promises to reduce vet workloads, boost client loyalty, and give pet owners instant access to verified health records.

The fast-growing vet chain hits a major milestone, but its venture-backed model reveals both the future of pet care and the challenges of rapid growth.

A new report reveals a massive care gap for 76 million US cats, offering a $34 billion roadmap for vets to boost revenue and improve feline health.

A new report reveals why large dogs face longer shelter stays. Low confidence, cost, and housing barriers are creating a crisis, but solutions are emerging.

A new venture platform backed by industry veterans launches a hands-on incubator to solve key challenges for startups in the booming pet technology ecosystem.

An injured 'begging' elephant's rescue via a state-of-the-art ambulance highlights a new chapter in the fight against animal exploitation in India.

Amidst snow and squalor, a massive rescue saved over 100 cats. Their journey to recovery highlights a story of cruelty, resilience, and legal triumph.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

As a gruesome screwworm parasite nears the Texas border, the FDA rushes to authorize treatments for dogs and cats, a critical step in national preparedness.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

Emmy-winner Brandon McMillan will unveil a revolutionary new line of dog training tools at the pet industry's premier event. What does he have in store?

Elanco's founding chairman and innovation head are leaving, marking a pivotal leadership shift as the animal health giant charts its post-spin-off future.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

In a strategic move, Central Garden & Pet appoints former exec Kay Schwichtenberg to its board, signaling a focus on animal health and institutional knowledge.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

As Caroline Dorsa retires, Biogen elects Dr. Maria Freire as its new chair, a strategic move placing deep scientific expertise at the helm for a critical period.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

AB Science's Masivet gets key FDA designation, paving the way for a new targeted cancer therapy for dogs and a major strategic win for the company.